NCT02822976View on ClinicalTrials.gov

HbA1c and Outcomes in the Critically Ill

CompletedOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

June 30, 2016

Conditions
Critical Illness
Trial Locations (1)

H3A 1A1

McGill University Health Centre: Royal Victoria Hospital and Montreal General Hospital, Montreal

All Listed Sponsors
lead

Roupen Hatzakorzian, MD

OTHER

NCT02822976 - HbA1c and Outcomes in the Critically Ill | Biotech Hunter | Biotech Hunter